Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Kempharm, Inc (KMPH)  
$4.56 0.02 (0.44%) as of 4:30 Wed 4/24


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 72,540,000
Market Cap: 330.78(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $4.14 - $7.08
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   KemPharm is a specialty pharmaceutical company focused on the discovery and development of treatments for central nervous system (CNS) and rare disease indications that allow it to target areas with unmet needs. Co.'s prodrug product candidate pipeline is focused on the idiopathic hypersomnia (IH) and other CNS/rare diseases. Co.'s approved product, AZSTARYS®, a once-daily treatment for attention deficit hyperactivity disorder in patients, age six years and older, contains its prodrug, serdexmethylphenidate (SDX). Co.'s primary clinical development product candidate, KP1077, is based on SDX, its prodrug of d-methlyphenidate and is in development for the treatment of IH and narcolepsy.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 36,240 103,219
Total Buy Value $0 $0 $182,489 $489,462
Total People Bought 0 0 5 11
Total Buy Transactions 0 0 10 26
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 149
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Anderson Thomas Director   •       •      –    2023-09-06 4 B $4.88 $48,764 D/D 10,000 10,000 2.39 17%     
   Clifton R. Laduane CFO, Secretary & Treasurer   •       •      –    2023-09-06 4 B $4.96 $4,959 D/D 1,000 15,309 2.66 17%     
   Schafer Joshua CCO & EVP, Bus. Development   •       •      –    2023-09-05 4 B $5.13 $2,565 D/D 500 3,500 2.66 18%     
   Bode John B Director   •       •      –    2023-09-05 4 B $5.13 $51,333 D/D 10,000 20,000 2.39 18%     
   Watton Corey Michael Director   •       •      –    2023-06-23 4 B $5.95 $1,636 D/D 275 1,000 2.31 -19%     
   Watton Corey Michael Director   •       •      –    2023-06-09 4 B $5.52 $1,794 D/D 325 725 2.31 -21%     
   Watton Corey Michael Director   •       •      –    2023-05-30 4 B $5.11 $2,042 D/D 400 400 2.31 -7%     
   Schafer Joshua CCO & EVP, Bus. Development   •       •      –    2023-05-19 4 B $5.42 $5,416 D/D 1,000 3,000 2.74 -8%     
   Bode John B Director   •       •      –    2023-05-18 4 B $5.04 $50,418 D/D 10,000 10,000 2.39 -3%     
   Clifton R. Laduane CFO, Secretary & Treasurer   •       •      –    2023-05-18 4 B $4.94 $13,562 D/D 2,740 13,742 2.74 -3%     
   Seymour Tamara A Director   •       •      –    2023-03-17 4 B $4.82 $2,502 D/D 519 719 2.31 -3%     
   Sangiovanni Timothy J. SVP, Corporate Controller   •       •      –    2023-03-10 4 B $4.14 $4,967 D/D 1,200 4,449 2.66 16%     
   Clifton R. Laduane CFO, Secretary & Treasurer   •       •      –    2023-03-10 4 B $4.15 $7,159 D/D 1,725 11,002 2.74 16%     
   Pascoe Richard W Chief Executive Officer   •       •      –    2023-03-09 4 B $4.20 $41,978 D/D 10,000 29,973 2.81 16%     
   Plooster Matthew R Director   •       •      –    2023-03-09 4 B $4.20 $46,148 D/D 11,000 18,500 2.39 16%     
   Tierney David S Director   •       •      –    2023-03-09 4 B $4.15 $20,732 D/D 5,000 10,835 2.39 16%     
   Pascoe Richard W Chief Executive Officer   •       •      –    2023-01-13 4 B $5.44 $51,679 D/D 9,500 19,973 2.81 6%     
   Clifton R. Laduane CFO, Secretary & Treasurer   •       •      –    2023-01-13 4 B $5.59 $3,690 D/D 635 9,277 2.66 6%     
   Mickle Christal M M Chief Product Dev. OfficerOffi   •       –      –    2023-01-06 3 IO $0.00 $0 I/I 0 121,219 7%     
   Mickle Christal M M Chief Product Dev. OfficerOffi   •       –      –    2023-01-06 3 IO $0.00 $0 D/D 0 11,972 7%     
   Clifton R. Laduane CFO, Secretary & Treasurer   •       •      –    2022-09-30 4 B $5.98 $5,981 D/D 1,000 8,109 2.74 -14%     
   Tierney David S Director   •       •      –    2022-05-25 4 B $4.39 $8,780 D/D 2,000 5,835 2.39 37%     
   Mickle Travis C President & CEO   •       •      –    2022-05-25 4 B $4.39 $43,900 I/I 10,000 11,034 2.66 37%     
   Mickle Travis C President & CEO   •       •      –    2022-05-25 4 B $4.36 $13,096 D/D 3,000 39,521 2.81 37%     
   Seymour Tamara A Director   •       •      –    2022-05-20 4 B $4.87 $974 D/D 200 200 2.31 25%     

  149 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed